Literature DB >> 1200108

Suppressive processes in binocular vision: ocular dominance and amblyopia.

C Porac, S Coren.   

Abstract

Recent suggestsions linking suppression observed in amblyopia ex anopsia with that manifested in normal ocular dominance coordinations were experimentally tested. Training procedures which normally alleviate functional amblyopic suppression were shown to have similar results in alleviating the suppression of the nondominant eye in visually normal observers. Methodological and theoretical implications of these results are discussed.

Entities:  

Mesh:

Year:  1975        PMID: 1200108     DOI: 10.1097/00006324-197510000-00001

Source DB:  PubMed          Journal:  Am J Optom Physiol Opt        ISSN: 0093-7002


  6 in total

1.  Eye preference within the context of binocular functions.

Authors:  Walter H Ehrenstein; Birgit E Arnold-Schulz-Gahmen; Wolfgang Jaschinski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-19       Impact factor: 3.117

2.  Monocular asymmetries in recognition after an eye movement: sighting dominance and dextrality.

Authors:  C Porac; S Coren
Journal:  Percept Psychophys       Date:  1979-01

Review 3.  A neurophysiological model for anomalous correspondence based on mechanisms of sensory fusion.

Authors:  J I Nelson
Journal:  Doc Ophthalmol       Date:  1981-03-31       Impact factor: 2.379

4.  The relationship between sighting dominance and the fading of a stabilized retinal image.

Authors:  C Porac; S Coren
Journal:  Percept Psychophys       Date:  1982-12

5.  Elucidation of the more myopic eye in anisometropia: the interplay of laterality, ocular dominance, and anisometropic magnitude.

Authors:  Siyu Jiang; Zheyi Chen; Hua Bi; Ruijing Xia; Ting Shen; Ling Zhou; Jun Jiang; Bin Zhang; Fan Lu
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

6.  Monocular and Binocular Temporal Visual Perception of Infantile Nystagmus.

Authors:  Avital Moshkovitz; Maria Lev; Uri Polat
Journal:  Sci Rep       Date:  2020-03-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.